Advances of mesenchymal stem cells and their derived extracellular vesicles as a promising therapy for acute respiratory distress syndrome: from bench to clinic

Acute respiratory distress syndrome (ARDS) is an acute inflammatory lung injury characterized by diffuse alveolar damage. The period prevalence of ARDS was 10.4% of ICU admissions in 50 countries. Although great progress has been made in supportive care, the hospital mortality rate of severe ARDS is...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhuang, Xiaoli, Jiang, Yu, Yang, Xiaofang, Fu, Lin, Luo, Lan, Dong, Ziyuan, Zhao, Ju, Hei, Feilong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497773/
https://www.ncbi.nlm.nih.gov/pubmed/37711624
http://dx.doi.org/10.3389/fimmu.2023.1244930

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10497773/
https://www.ncbi.nlm.nih.gov/pubmed/37711624
http://dx.doi.org/10.3389/fimmu.2023.1244930

Ejemplares similares